{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:40:36Z","timestamp":1793090436934,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105587","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:02:48Z","timestamp":1788793368000},"page":"105587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From cellular therapy to biologics: Non-viral delivery strategies for in vivo CAR-T engineering"],"prefix":"10.1016","volume":"227","author":[{"given":"Shuyi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihui","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8449-5551","authenticated-orcid":false,"given":"Peiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/acsami.8b18843","article-title":"Ligand density and linker length are critical factors for multivalent nanoparticle-receptor interactions","volume":"11","author":"Abstiens","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105587_bib2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nbt.4086","article-title":"IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor","volume":"36","author":"Adachi","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105587_bib3","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.immuni.2023.09.001","article-title":"Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells","volume":"56","author":"Agarwal","year":"2023","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105587_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s42003-021-02995-1","article-title":"The interplay between membrane topology and mechanical forces in regulating T cell receptor activity","volume":"5","author":"Al-Aghbar","year":"2022","journal-title":"Commun. Biol."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105587_bib6","article-title":"Polymeric nanoparticles with neglectable protein corona","volume":"16","author":"Alberg","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.critrevonc.2026.105587_bib7","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.2147\/IJN.S472433","article-title":"Chitosan nanoparticles for targeted cancer therapy: a review of stimuli-responsive, passive, and active targeting strategies","volume":"19","author":"Al-Shadidi","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"44","key":"10.1016\/j.critrevonc.2026.105587_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310395","article-title":"Spleen SORT LNP generated in situ CAR T cells extend survival in a mouse model of lymphoreplete B cell lymphoma","volume":"62","author":"Alvarez-Benedicto","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.critrevonc.2026.105587_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","article-title":"N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice","volume":"217","author":"Andries","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105587_bib10","article-title":"Lipid nanoparticles for engineering next generation CAR T cell immunotherapy","author":"Ang","year":"2025","journal-title":"Nanoscale Horiz."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105587_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304378","article-title":"Vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105587_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011759","article-title":"T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticles","volume":"13","author":"Bimbo","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105587_bib13","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.ymthe.2018.05.007","article-title":"PiggyBac-engineered T cells expressing CD19-specific CARs that lack IgG1 Fc spacers have potent activity against B-ALL xenografts","volume":"26","author":"Bishop","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105587_bib14","article-title":"vivo chimeric antigen receptor (CAR)-T cell therapy","author":"Bot","year":"2025","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105587_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nm1398","article-title":"Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer","volume":"12","author":"Brown","year":"2006","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib16","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-024-46504-4","article-title":"Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas","volume":"15","author":"Broz","year":"2024","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105587_bib17","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2024.19462","article-title":"CAR T cells and T-cell therapies for cancer: a translational science review","volume":"332","author":"Brudno","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2026.105587_bib18","article-title":"From lab to industrial development of lipid nanocarriers using quality by design approach","volume":"8","author":"Buya","year":"2024","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.critrevonc.2026.105587_bib19","article-title":"An inherent T cell-activating mRNA delivery carrier for in vivo CAR T generation","author":"Cao","year":"2026","journal-title":"Nat. Mater."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105587_bib20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","article-title":"A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles","volume":"20","author":"Chen","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"Pt 1","key":"10.1016\/j.critrevonc.2026.105587_bib21","article-title":"Administration of lipid nanoparticle-encapsulated mRNA encoding CCR7, CXCL16 and GITRL effectively mobilizes antitumor T cell immunity","volume":"318","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105587_bib22","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1016\/j.ymthe.2024.09.019","article-title":"Synergistic integration of mRNA-LNP with CAR-engineered immune cells: pioneering progress in immunotherapy","volume":"32","author":"Chen","year":"2024","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105587_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105587_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.it.2024.07.009","article-title":"The extracellular matrix in solid tumor immunotherapy","volume":"45","author":"Cho","year":"2024","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105587_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/17425240903025744","article-title":"Nuclear targeting of viral and non-viral DNA","volume":"6","author":"Chowdhury","year":"2009","journal-title":"Expert. Opin. Drug. Deliv."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105587_bib26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41563-024-01934-9","article-title":"Lipid discovery for mRNA delivery guided by machine learning","volume":"23","author":"van der Meel","year":"2024","journal-title":"Nat. Mater."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105587_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102520","article-title":"Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers","volume":"36","author":"Dietmair","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"28","key":"10.1016\/j.critrevonc.2026.105587_bib28","doi-asserted-by":"crossref","first-page":"19218","DOI":"10.1021\/jacs.4c04331","article-title":"Stimuli-responsive mRNA vaccines to induce robust CD8(+) T cell response via ROS-mediated innate immunity boosting","volume":"146","author":"Dong","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105587_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/qjmed\/hcaf075","article-title":"Advancements in gene therapy for lung cancer: from genetic insights to clinical applications","volume":"118","author":"Doroudian","year":"2025","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105587_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nano.2012.05.015","article-title":"Effect of ligand density, receptor density, and nanoparticle size on cell targeting","volume":"9","author":"Elias","year":"2013","journal-title":"Nanomedicine"},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105587_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/marc.202500428","article-title":"Polyglycerol-based lipids: a next-generation alternative to peg in lipid nanoparticles for advanced drug delivery systems","volume":"47","author":"Ensminger","year":"2026","journal-title":"Macromol. Rapid Commun."},{"issue":"7643","key":"10.1016\/j.critrevonc.2026.105587_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"issue":"62","key":"10.1016\/j.critrevonc.2026.105587_bib33","article-title":"Harnessing gene editing technology for tumor microenvironment modulation: an emerging anticancer strategy","volume":"30","author":"Feng","year":"2024","journal-title":"Chemistry"},{"key":"10.1016\/j.critrevonc.2026.105587_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113906","article-title":"Impact of tail unsaturation in ionizable lipids on mRNA delivery efficiency and immunogenicity of lipid nanoparticles","volume":"384","author":"Ge","year":"2025","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105587_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood-2017-01-761320","article-title":"CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies","volume":"130","author":"Gomes-Silva","year":"2017","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105587_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/v12091016","article-title":"Lentiviral vector pseudotypes: precious tools to improve gene modification of hematopoietic cells for research and gene therapy","volume":"12","author":"Gutierrez-Guerrero","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105587_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12668-025-02144-6","article-title":"Superparamagnetic iron oxide nanoparticles: multifunctional targeted platforms for cancer detection and combination therapy","volume":"15","author":"Haider","year":"2025","journal-title":"BioNanoScience"},{"key":"10.1016\/j.critrevonc.2026.105587_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"30","key":"10.1016\/j.critrevonc.2026.105587_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301515","article-title":"Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering","volume":"12","author":"Hamilton","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54877-9","article-title":"Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity","volume":"15","author":"Hamouda","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105587_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105587_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz4316","article-title":"Nanoparticle elasticity regulates phagocytosis and cancer cell uptake","volume":"6","author":"Hui","year":"2020","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105587_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201695","article-title":"Understanding intracellular biology to improve mRNA delivery by lipid nanoparticles","volume":"7","author":"Hunter","year":"2023","journal-title":"Small Methods"},{"issue":"6753","key":"10.1016\/j.critrevonc.2026.105587_bib46","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105587_bib47","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s12276-024-01220-3","article-title":"Molecular mechanisms of circular RNA translation","volume":"56","author":"Hwang","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","article-title":"Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes","volume":"112","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105587_bib49","doi-asserted-by":"crossref","first-page":"702","DOI":"10.15252\/emmm.201505869","article-title":"Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer","volume":"8","author":"Jin","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105587_bib50","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/v2071382","article-title":"Targeting microRNA-122 to treat hepatitis C virus infection","volume":"2","author":"Jopling","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.critrevonc.2026.105587_bib51","first-page":"86","article-title":"Engineering LNPs with polysarcosine lipids for mRNA delivery","volume":"37","author":"Kang","year":"2024","journal-title":"Bioact. Mater."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105587_bib52","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1172\/JCI86721","article-title":"Phase I trials using sleeping beauty to generate CD19-specific CAR T cells","volume":"126","author":"Kebriaei","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.critrevonc.2026.105587_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122896","article-title":"Poly(beta-amino ester) polymer library with monomer variation for mRNA delivery","volume":"314","author":"Kim","year":"2025","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105587_bib54","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"issue":"31","key":"10.1016\/j.critrevonc.2026.105587_bib55","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","article-title":"Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG","volume":"41","author":"Kozma","year":"2023","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105587_bib56","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gt.2010.31","article-title":"Progress and prospects: nuclear import of nonviral vectors","volume":"17","author":"Lam","year":"2010","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105587_bib57","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.ymthe.2026.02.020","article-title":"Reprogramming CD22 CAR-T cells in vivo using CD8-targeted mRNA-LNPs to treat hematological malignancies","volume":"34","author":"Lemgart","year":"2026","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105587_bib58","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41577-025-01174-1","article-title":"vivo CAR engineering for immunotherapy","volume":"25","author":"Li","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"Pt A","key":"10.1016\/j.critrevonc.2026.105587_bib59","article-title":"Multiple tail ionizable lipids improve in vivo mRNA delivery efficiency with biosafety","volume":"667","author":"Liu","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105587_bib60","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1021\/acs.bioconjchem.8b00443","article-title":"Vitro transcribed mRNA vaccines with programmable stimulation of innate immunity","volume":"29","author":"Loomis","year":"2018","journal-title":"Bioconjug. Chem."},{"issue":"43","key":"10.1016\/j.critrevonc.2026.105587_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady5579","article-title":"A multistep platform identifies spleen-tropic lipid nanoparticles for in vivo T cell-targeted delivery of gene-editing proteins","volume":"11","author":"Lu","year":"2025","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105587_bib62","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11095-025-03890-8","article-title":"Mechanism of pH-sensitive amphiphilic endosomal escape of ionizable lipid nanoparticles for cytosolic nucleic acid delivery","volume":"42","author":"Lu","year":"2025","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105587_bib63","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1172\/JCI138473","article-title":"Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities","volume":"130","author":"Magnani","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105587_bib64","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1021\/acsptsci.1c00188","article-title":"Enhancing CAR-T cell therapy with functional nucleic acids","volume":"4","author":"Maru","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70680-4","article-title":"Impact of mixing and shaking on mRNA-LNP drug product quality characteristics","volume":"14","author":"Matthessen","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105587_bib66","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2026.105587_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.01.152","article-title":"Biological effects of formation of protein corona onto nanoparticles","volume":"175","author":"Mishra","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105587_bib68","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1021\/acsnano.6b07600","article-title":"Direct cytosolic delivery of CRISPR\/Cas9-ribonucleoprotein for efficient gene editing","volume":"11","author":"Mout","year":"2017","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66737-1","article-title":"Multiplex gene-editing strategy to engineer allogeneic EGFR-targeting CAR T-cells with improved efficacy against solid tumors","volume":"16","author":"Murray","year":"2025","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105587_bib70","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41565-021-00982-5","article-title":"Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety","volume":"16","author":"Nguyen","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib71","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105587_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101566","article-title":"Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases","volume":"33","author":"Razavi","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105587_bib73","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41551-023-01013-5","article-title":"A lentiviral vector for the production of T cells with an inducible transgene and a constitutively expressed tumour-targeting receptor","volume":"7","author":"Reichenbach","year":"2023","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105587_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102618","article-title":"Sustained and specific multiplexed immune checkpoint modulation in CAR T cells induced by targeted epigenome editing","volume":"36","author":"Roman Azcona","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"7714","key":"10.1016\/j.critrevonc.2026.105587_bib75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105587_bib76","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/s41565-025-02044-6","article-title":"Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines","volume":"20","author":"Rudra","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105587_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008656","article-title":"Placental circulating T cells: a novel, allogeneic CAR-T cell platform with preserved T-cell stemness, more favorable cytokine profile, and durable efficacy compared to adult PBMC-derived CAR-T","volume":"12","author":"Ruggeri Barbaro","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"6576","key":"10.1016\/j.critrevonc.2026.105587_bib78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105587_bib79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2022.06.052","article-title":"Targeted delivery of lipid nanoparticle to lymphatic endothelial cells via anti-podoplanin antibody","volume":"349","author":"Sakurai","year":"2022","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105587_bib80","article-title":"Smart lipid-based nanoparticles in lung cancer treatment: current status and future directions","volume":"6","author":"Shahrivar","year":"2023","journal-title":"Adv. Ther."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105587_bib81","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105587_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113879","article-title":"A perspective on the apparent pKa of ionizable lipids in mRNA-LNPs","volume":"384","author":"Simonsen","year":"2025","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105587_bib83","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nnano.2017.57","article-title":"situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers","volume":"12","author":"Smith","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.32604\/or.2024.053069","article-title":"Engendered nanoparticles for treatment of brain tumors","volume":"33","author":"Soleymani","year":"2025","journal-title":"Oncol. Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105587_bib85","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1007\/s11468-024-02469-0","article-title":"Laser-fabricated metal oxide core\u2013shell nanoparticles for biomedical applications: a mini review","volume":"20","author":"Talib","year":"2025","journal-title":"Plasmonics"},{"issue":"Pt A","key":"10.1016\/j.critrevonc.2026.105587_bib86","article-title":"Dominant negative TGFbeta receptor II and truncated TIM3 enhance the antitumor efficacy of CAR-T-cell therapy in prostate cancer","volume":"124","author":"Tang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"42","key":"10.1016\/j.critrevonc.2026.105587_bib87","doi-asserted-by":"crossref","first-page":"38865","DOI":"10.1021\/jacs.5c14870","article-title":"Computationally aided design of ionizable cholesteryl lipids for lipid nanoparticles to modulate hepatic mrna accumulation","volume":"147","author":"Teng","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105587_bib88","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","article-title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs","volume":"29","author":"Tombacz","year":"2021","journal-title":"Mol. Ther."},{"issue":"35","key":"10.1016\/j.critrevonc.2026.105587_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202313791","article-title":"Expanding RNAi to kidneys, lungs, and spleen via selective organ targeting (SORT) siRNA lipid nanoparticles","volume":"36","author":"Vaidya","year":"2024","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105587_bib90","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","article-title":"Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen","volume":"21","author":"Vardhana","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105587_bib91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2018.05.034","article-title":"The proton sponge hypothesis: fable or fact?","volume":"129","author":"Vermeulen","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.critrevonc.2026.105587_bib92","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.copbio.2018.01.025","article-title":"A guide to manufacturing CAR T cell therapies","volume":"53","author":"Vormittag","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105587_bib93","article-title":"Synergically enhanced anti-tumor immunity of in vivo panCAR by circRNA vaccine boosting","volume":"6","author":"Wang","year":"2025","journal-title":"Cell. Rep. Med."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105587_bib94","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMc2509522","article-title":"Vivo CD19 CAR T-cell therapy for refractory systemic lupus erythematosus","volume":"393","author":"Wang","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501475","article-title":"Co-delivery of multiple RNAs via lipid nanoparticles enables precise gene editing of CAR-T cells","volume":"15","author":"Wang","year":"2026","journal-title":"Adv. Healthc. Mater."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105587_bib96","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41587-024-02490-y","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","volume":"43","author":"Witten","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib97","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","article-title":"Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1alpha-mediated glycolytic reprogramming","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105587_bib98","first-page":"3547","article-title":"A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants","volume":"7","author":"Xu","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib99","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41467-024-45422-9","article-title":"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","volume":"15","author":"Xue","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105587_bib100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41408-022-00694-6","article-title":"Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study","volume":"12","author":"Yang","year":"2022","journal-title":"Blood Cancer J."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105587_bib101","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009910","article-title":"CAR T cells secreting NGF-neutralizing scFv enhance efficacy in clear cell renal cell carcinoma by relieving immunosuppression through immunosympathectomy","volume":"12","author":"Yang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib102","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1039\/C6NR07179A","article-title":"Kinetics of receptor-mediated endocytosis of elastic nanoparticles","volume":"9","author":"Yi","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.critrevonc.2026.105587_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108937","article-title":"Crosstalk between macrophages and innate lymphoid cells (ILCs) in diseases","volume":"110","author":"Yin","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105587_bib104","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.accounts.5c00522","article-title":"Ionizable lipid nanoparticles for mRNA delivery: internal self-assembled inverse mesophase structure and endosomal escape","volume":"58","author":"Yu","year":"2025","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.critrevonc.2026.105587_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123047","article-title":"Targeted LNPs deliver IL-15 superagonists mRNA for precision cancer therapy","volume":"317","author":"Yu","year":"2025","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105587_bib106","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.cell.2024.04.023","article-title":"Osr2 functions as a biomechanical checkpoint to aggravate CD8(+) T cell exhaustion in tumor","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105587_bib107","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","article-title":"Regulatory T cells in immune checkpoint blockade antitumor therapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105587_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102686","article-title":"Pharmacometric modeling of lipid nanoparticle-encapsulated mRNA therapeutics and vaccines: a systematic review","volume":"36","author":"Zhang","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105587_bib109","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41423-024-01228-9","article-title":"Specific ECM degradation potentiates the antitumor activity of CAR-T cells in solid tumors","volume":"21","author":"Zheng","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105587_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1091779","article-title":"The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105587_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70310","article-title":"Heparanase-loaded CAR T extracellular vesicles remodel the colorectal tumour microenvironment and boost T cell antitumor immunity","volume":"15","author":"Zhu","year":"2026","journal-title":"J. Extracell. Vesicles"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:05:38Z","timestamp":1793088338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826004749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":111,"alternative-id":["S1040842826004749"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105587","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From cellular therapy to biologics: Non-viral delivery strategies for in vivo CAR-T engineering","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105587"}}